关于PSCA rs2294008多态和胃癌的关联研究:一个元分析
HangLong Li1, Qiang Zhao2, ShuHan Si1
1Changzhi Medical College, Changzhi City, Shanxi Province, China.
Frontiers in gastroenterology (Lausanne, Switzerland)
|March 13, 2026
概括
前列腺干细胞抗原 (PSCA) rs2294008 C>T多态性增加了胃癌的风险. 这一遗传因素与扩散性,非心脏性和Helicobacter pylori阳性胃癌有关,特别是在白人群体中.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 前列腺干细胞抗原 (PSCA) rs2294008 C>T多态性和胃癌易感性之间的关联仍在争论中.
- 之前的研究对这种遗传联系产生了相互矛盾的结果.
研究的目的:
- 为了澄清PSCA rs2294008多态和胃癌风险之间的关系.
- 通过全面的元分析,调查影响胃癌易感性的因素.
主要方法:
- 对2022年4月16日之前发表的研究进行了元分析,来源于PubMed,Springer,EMBASE和Web of Science.
- 使用几率比率 (OR) 和95%置信区间来分析风险模型与胃癌之间的关联.
- 进行了子组分析,以探索基于癌症类型,Helicobacter pylori状态,种族和吸烟的风险差异.
主要成果:
- 证实PSCA rs2294008多态性显著增加胃癌的风险.
- 扩散性胃癌,非心脏性胃癌以及Helicobacter pylori阳性个体的病例中观察到易感性增加.
- 与亚洲人群相比,白人群体的风险更高,全基因组关联分析加强了PSCA与胃癌的关联.
- 一项异常发现表明,吸烟降低了胃癌的易感性,需要进一步调查.
结论:
- PSCA rs2294008多态性是胃癌的危险因素,特别是在特定的子组中.
- 需要进一步的前性研究,采用更大的样本大小,以阐明吸烟在胃癌易感性中的作用.
相关概念视频
Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K
Single Nucleotide Polymorphisms-SNPs
19.4K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.4K
Pharmacogenomics: Identification of New Drug Targets
61
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
61
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61


